Showing results (71-80 of 5,905) with videos related to
Sort By:
Pageof 591
Cancer Genetics and Cytogenetics|August 8, 2002
Clinical significance of allelic loss of chromosome region 5q22.3 approximately q23.2 in nonpapillary renal cell carcinomaKazuhiro Nagao, Satoru Yoshihiro, Hideyasu Matsuyama, et al.Cancer Genetics and Cytogenetics|August 8, 2002
Refractory anemia with ring sideroblasts associated with i(17q) and mutation of the TP53 geneVladimir Lazarević, Vesna Djordjević, Zvonko Magić, et al.Cancer Genetics and Cytogenetics|May 9, 2002
Cytogenetic and molecular analysis of early stage renal cell carcinomas in a family with a translocation (2;3)(q35;q21)Danielle Bodmer, Marc Eleveld, Marjolijn Ligtenberg, et al.Cancer Genetics and Cytogenetics|May 9, 2002
Significance of cytogenetic and fluorescence in situ hybridization analysis in evaluating antichronic myeloid leukemia efficacy of different immune effector cellsChun Rong Tong, Bo Hong, Jing Ying Qiu, et al.Cancer Genetics and Cytogenetics|July 17, 2001
Cytogenetic aberrations in adult acute lymphocytic leukemia: optimal technique may influence the resultsR K Pedersen, G B Kerndrup, A G Sørensen, et al.Cancer Genetics and Cytogenetics|July 17, 2001
Derivative (1;18)(q10;q10): a recurrent and novel unbalanced translocation involving 1q in myeloid disordersT S Wan, S K Ma, W Y Au, et al.Cancer Genetics and Cytogenetics|July 17, 2001
Chromosomal aberrations in Bloom syndrome patients with myeloid malignanciesB Poppe, H Van Limbergen, N Van Roy, et al.Cancer Genetics and Cytogenetics|May 10, 2001
The application of comparative genomic hybridization as an additional tool in the chromosome analysis of acute myeloid leukemia and myelodysplastic syndromesM H Kim, J Stewart, C Devlin, et al.Cancer Genetics and Cytogenetics|May 10, 2001
Chromosomal analyses of 52 cases of follicular lymphoma with t(14;18), including blastic/blastoid variantA N Mohamed, M Palutke, L Eisenberg, et al.Cancer Genetics and Cytogenetics|April 12, 2001
Tetrasomy 8 is associated with a major cellular proliferative advantage and a poor prognosis. two cases of myeloid hematologic disorders and review of the literatureJ Yan, D Marceau, R DrouinPageof 591